Dr. Judith Rapoport, a pioneering child psychiatrist whose research fundamentally reshaped the clinical understanding of childhood-onset obsessive-compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD), died on March 7, 2026, in Washington, D.C. She was 92. The cause of death was lung cancer, according to family statements.
Throughout a career spanning more than five decades, Dr. Rapoport served as a central figure at the National Institute of Mental Health (NIMH), where she led the Child Psychiatry Branch. Her work moved the field away from purely psychodynamic interpretations of childhood behavioral issues, pushing instead toward a rigorous, neurobiological framework. Her investigations into the brain mechanisms underlying OCD provided some of the earliest evidence that the condition was rooted in biological dysfunction rather than environmental or parental influence.
A Shift Toward Neurobiology
Before Dr. Rapoport’s emergence in the field, child psychiatry was often dominated by psychoanalytic theories that placed significant emphasis on early childhood experiences and family dynamics. As a researcher at the NIMH, she challenged these paradigms by utilizing emerging neuroimaging technologies to study the developing brain. Her 1989 book, The Boy Who Couldn’t Stop Washing, brought the reality of childhood OCD to a wider public audience, detailing the experiences of patients and providing a scientific basis for the condition’s treatment.
Her research consistently demonstrated that OCD in children was not a rare phenomenon but a distinct, manageable condition. By conducting longitudinal studies, she tracked the natural history of these disorders, helping clinicians distinguish between typical childhood development and clinical pathology. This data-driven approach was instrumental in legitimizing pediatric psychopharmacology and behavioral interventions as standard care.
Academic Contributions and Institutional Impact
Dr. Rapoport was born in New York City on July 12, 1933. She pursued her medical education with an eye toward understanding the biological underpinnings of behavior, eventually becoming one of the most cited researchers in the National Institutes of Health (NIH) system. Her influence extended beyond her own laboratory; she mentored generations of child psychiatrists who now lead departments across the United States and Europe.
Her colleagues often noted her rigorous adherence to the scientific method, even when her findings contradicted prevailing wisdom. By identifying structural brain differences in children with ADHD and OCD, she provided a roadmap for future genetic and neuroscientific research. Her work is frequently cited in current clinical guidelines published by the American Academy of Child and Adolescent Psychiatry (AACAP), which continue to emphasize the neurobiological foundations she helped establish.
The Scope of Her Influence
Beyond her research, Dr. Rapoport was a vocal advocate for the integration of mental health care into general pediatric practice. She argued that early detection of behavioral disorders could prevent long-term functional impairment in children. Her insistence on evidence-based medicine ensured that the treatment of pediatric patients moved toward therapies that were supported by clinical trials, such as cognitive-behavioral therapy (CBT) and targeted medication management.
She remained an active presence in the scientific community well into her later years, contributing to peer-reviewed journals and advising on national mental health policy. Her death marks the end of an era for the NIMH, where she spent the bulk of her professional life. She is survived by her family, who have requested privacy as they navigate this transition.
The academic and medical communities are expected to hold formal tributes in the coming months, with details to be shared via the National Institutes of Health official news portal. Readers who wish to share their own experiences or reflections regarding Dr. Rapoport’s impact on clinical practice are encouraged to participate in the ongoing discussions on our platform.